{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T05:22:41Z","timestamp":1737696161731,"version":"3.33.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82170181"],"award-info":[{"award-number":["82170181"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Natural Science Foundation","award":["7222027"],"award-info":[{"award-number":["7222027"]}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2022YFF1502000"],"award-info":[{"award-number":["2022YFF1502000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Physician Scientist Training Project","award":["BJPSTP-2024-01"],"award-info":[{"award-number":["BJPSTP-2024-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Big Data"],"DOI":"10.1186\/s40537-025-01067-z","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T16:56:57Z","timestamp":1737651417000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Refining prognostic assessment of diffuse large B-cell lymphoma: insights from multi-omics and single-cell analysis unveil SRM as a key target for regulating immunotherapy"],"prefix":"10.1186","volume":"12","author":[{"given":"Xiaojie","family":"Liang","sequence":"first","affiliation":[]},{"given":"Jia","family":"Guo","sequence":"additional","affiliation":[]},{"given":"Baiwei","family":"Luo","sequence":"additional","affiliation":[]},{"given":"Weixiang","family":"Lu","sequence":"additional","affiliation":[]},{"given":"Qiumin","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Yeling","family":"Deng","sequence":"additional","affiliation":[]},{"given":"Yunong","family":"Yang","sequence":"additional","affiliation":[]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"issue":"12","key":"1067_CR1","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.1002\/art.22277","volume":"54","author":"E Baecklund","year":"2006","unstructured":"Baecklund E, Backlin C, Iliadou A, Granath F, Ekbom A, Amini RM, et al. Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis. Arthritis Rheum. 2006;54(12):3774\u201381.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1067_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13045-020-01011-z","volume":"13","author":"L Wang","year":"2020","unstructured":"Wang L, Li LR, Young KH. New agents and regimens for diffuse large B cell lymphoma. J Hematol Oncol. 2020;13(1):175.","journal-title":"J Hematol Oncol"},{"issue":"7","key":"1067_CR3","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/s41556-020-0532-x","volume":"22","author":"T Roider","year":"2020","unstructured":"Roider T, Seufert J, Uvarovskii A, Frauhammer F, Bordas M, Abedpour N, et al. Dissecting intratumour heterogeneity of nodal B-cell lymphomas at the transcriptional, genetic and drug-response levels. Nat Cell Biol. 2020;22(7):896\u2013906.","journal-title":"Nat Cell Biol"},{"issue":"10","key":"1067_CR4","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.ccell.2021.08.011","volume":"39","author":"CB Steen","year":"2021","unstructured":"Steen CB, Luca BA, Esfahani MS, Azizi A, Sworder BJ, Nabet BY, et al. The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma. Cancer Cell. 2021;39(10):1422-37.e10.","journal-title":"Cancer Cell"},{"issue":"6","key":"1067_CR5","doi-asserted-by":"publisher","first-page":"101042831770622","DOI":"10.1177\/1010428317706227","volume":"39","author":"B Xu","year":"2017","unstructured":"Xu B, Wang T. Intimate cross-talk between cancer cells and the tumor microenvironment of B-cell lymphomas: the key role of exosomes. Tumour Biol. 2017;39(6):1010428317706227.","journal-title":"Tumour Biol"},{"issue":"6","key":"1067_CR6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.trecan.2019.05.001","volume":"5","author":"UE H\u00f6pken","year":"2019","unstructured":"H\u00f6pken UE, Rehm A. Targeting the tumor microenvironment of leukemia and lymphoma. Trends Cancer. 2019;5(6):351\u201364.","journal-title":"Trends Cancer"},{"key":"1067_CR7","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3389\/fonc.2018.00288","volume":"8","author":"D Kumar","year":"2018","unstructured":"Kumar D, Xu ML. Microenvironment cell contribution to lymphoma immunity. Front Oncol. 2018;8:288.","journal-title":"Front Oncol"},{"issue":"18","key":"1067_CR8","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1182\/blood-2017-12-820605","volume":"131","author":"DW Scott","year":"2018","unstructured":"Scott DW, King RL, Staiger AM, Ben-Neriah S, Jiang A, Horn H, et al. High-grade B-cell lymphoma with MYC and BCL2 and\/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology. Blood. 2018;131(18):2060\u20134.","journal-title":"Blood"},{"issue":"22","key":"1067_CR9","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","volume":"359","author":"G Lenz","year":"2008","unstructured":"Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao H, et al. Stromal gene signatures in large-B-cell lymphomas. N Engl J Med. 2008;359(22):2313\u201323.","journal-title":"N Engl J Med"},{"issue":"6","key":"1067_CR10","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1158\/2159-8290.CD-20-0839","volume":"11","author":"N Kotlov","year":"2021","unstructured":"Kotlov N, Bagaev A, Revuelta MV, Phillip JM, Cacciapuoti MT, Antysheva Z, et al. Clinical and biological subtypes of B-cell lymphoma revealed by microenvironmental signatures. Cancer Discov. 2021;11(6):1468\u201389.","journal-title":"Cancer Discov"},{"issue":"9","key":"1067_CR11","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1038\/leu.2012.83","volume":"26","author":"C Visco","year":"2012","unstructured":"Visco C, Li Y, Xu-Monette ZY, Miranda RN, Green TM, Li Y, et al. Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Leukemia. 2012;26(9):2103\u201313.","journal-title":"Leukemia"},{"issue":"9","key":"1067_CR12","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1158\/1078-0432.CCR-16-1922","volume":"23","author":"S Dubois","year":"2017","unstructured":"Dubois S, Viailly PJ, Bohers E, Bertrand P, Ruminy P, Marchand V, et al. Biological and clinical relevance of associated genomic alterations in MYD88 L265P and non-L265P-mutated diffuse large B-cell lymphoma: analysis of 361 cases. Clin Cancer Res. 2017;23(9):2232\u201344.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1067_CR13","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1200\/JCO.18.01314","volume":"37","author":"C Sha","year":"2019","unstructured":"Sha C, Barrans S, Cucco F, Bentley MA, Care MA, Cummin T, et al. Molecular high-grade B-cell lymphoma: defining a poor-risk group that requires different approaches to therapy. J Clin Oncol. 2019;37(3):202\u201312.","journal-title":"J Clin Oncol"},{"issue":"15","key":"1067_CR14","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","volume":"378","author":"R Schmitz","year":"2018","unstructured":"Schmitz R, Wright GW, Huang DW, Johnson CA, Phelan JD, Wang JQ, et al. Genetics and pathogenesis of diffuse large B-cell lymphoma. N Engl J Med. 2018;378(15):1396\u2013407.","journal-title":"N Engl J Med"},{"issue":"20","key":"1067_CR15","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1182\/blood.2019003535","volume":"135","author":"SE Lacy","year":"2020","unstructured":"Lacy SE, Barrans SL, Beer PA, Painter D, Smith AG, Roman E, et al. Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report. Blood. 2020;135(20):1759\u201371.","journal-title":"Blood"},{"issue":"1\u20132","key":"1067_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","volume":"160","author":"MS Rooney","year":"2015","unstructured":"Rooney MS, Shukla SA, Wu CJ, Getz G, Hacohen N. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell. 2015;160(1\u20132):48\u201361.","journal-title":"Cell"},{"issue":"4","key":"1067_CR17","doi-asserted-by":"publisher","first-page":"482","DOI":"10.15252\/emmm.201606975","volume":"9","author":"B Bian","year":"2017","unstructured":"Bian B, Bigonnet M, Gayet O, Loncle C, Maignan A, Gilabert M, et al. Gene expression profiling of patient-derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine efforts. EMBO Mol Med. 2017;9(4):482\u201397.","journal-title":"EMBO Mol Med"},{"issue":"10","key":"1067_CR18","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/ng.3398","volume":"47","author":"RA Moffitt","year":"2015","unstructured":"Moffitt RA, Marayati R, Flate EL, Volmar KE, Loeza SGH, Hoadley KA, et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat Genet. 2015;47(10):1168\u201378.","journal-title":"Nat Genet"},{"key":"1067_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"issue":"43","key":"1067_CR20","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"1067_CR21","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"6","key":"1067_CR22","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nbt.2530","volume":"31","author":"J Hu","year":"2013","unstructured":"Hu J, Locasale JW, Bielas JH, O\u2019Sullivan J, Sheahan K, Cantley LC, et al. Heterogeneity of tumor-induced gene expression changes in the human metabolic network. Nat Biotechnol. 2013;31(6):522\u20139.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"1067_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1000792","volume":"6","author":"JA Eddy","year":"2010","unstructured":"Eddy JA, Hood L, Price ND, Geman D. Identifying tightly regulated and variably expressed networks by Differential Rank Conservation (DIRAC). PLoS Comput Biol. 2010;6(5): e1000792.","journal-title":"PLoS Comput Biol"},{"key":"1067_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.0105-2896.2006.00373.x","volume":"210","author":"AL Shaffer","year":"2006","unstructured":"Shaffer AL, Wright G, Yang L, Powell J, Ngo V, Lamy L, et al. A library of gene expression signatures to illuminate normal and pathological lymphoid biology. Immunol Rev. 2006;210:67\u201385.","journal-title":"Immunol Rev"},{"issue":"6","key":"1067_CR25","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","volume":"39","author":"A Bagaev","year":"2021","unstructured":"Bagaev A, Kotlov N, Nomie K, Svekolkin V, Gafurov A, Isaeva O, et al. Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. Cancer Cell. 2021;39(6):845-65.e7.","journal-title":"Cancer Cell"},{"issue":"1","key":"1067_CR26","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D, et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18(1):248\u201362.","journal-title":"Cell Rep"},{"issue":"1","key":"1067_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","volume":"165","author":"W Hugo","year":"2016","unstructured":"Hugo W, Zaretsky JM, Sun L, Song C, Moreno BH, Hu-Lieskovan S, et al. Genomic and transcriptomic features of response to Anti-PD-1 therapy in metastatic melanoma. Cell. 2016;165(1):35\u201344.","journal-title":"Cell"},{"issue":"7693","key":"1067_CR28","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, et al. TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554(7693):544\u20138.","journal-title":"Nature"},{"issue":"3","key":"1067_CR29","doi-asserted-by":"publisher","first-page":"251","DOI":"10.4103\/0019-5154.182416","volume":"61","author":"A Hazra","year":"2016","unstructured":"Hazra A, Gogtay N. Biostatistics series module 3: comparing groups: numerical variables. Indian J Dermatol. 2016;61(3):251\u201360.","journal-title":"Indian J Dermatol"},{"issue":"6769","key":"1067_CR30","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403(6769):503\u201311.","journal-title":"Nature"},{"issue":"25","key":"1067_CR31","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1056\/NEJMoa012914","volume":"346","author":"A Rosenwald","year":"2002","unstructured":"Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346(25):1937\u201347.","journal-title":"N Engl J Med"},{"issue":"6","key":"1067_CR32","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/s41588-020-0630-5","volume":"52","author":"A Jim\u00e9nez-S\u00e1nchez","year":"2020","unstructured":"Jim\u00e9nez-S\u00e1nchez A, Cybulska P, Mager KL, Koplev S, Cast O, Couturier DL, et al. Unraveling tumor-immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy. Nat Genet. 2020;52(6):582\u201393.","journal-title":"Nat Genet"},{"issue":"6","key":"1067_CR33","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.cell.2017.11.013","volume":"171","author":"RM Kortlever","year":"2017","unstructured":"Kortlever RM, Sodir NM, Wilson CH, Burkhart DL, Pellegrinet L, Brown Swigart L, et al. Myc cooperates with ras by programming inflammation and immune suppression. Cell. 2017;171(6):1301-15.e14.","journal-title":"Cell"},{"issue":"6282","key":"1067_CR34","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1126\/science.aac9935","volume":"352","author":"SC Casey","year":"2016","unstructured":"Casey SC, Tong L, Li Y, Do R, Walz S, Fitzgerald KN, et al. MYC regulates the antitumor immune response through CD47 and PD-L1. Science. 2016;352(6282):227\u201331.","journal-title":"Science"},{"issue":"12","key":"1067_CR35","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/nrc2231","volume":"8","author":"N Meyer","year":"2008","unstructured":"Meyer N, Penn LZ. Reflecting on 25 years with MYC. Nat Rev Cancer. 2008;8(12):976\u201390.","journal-title":"Nat Rev Cancer"},{"issue":"7418","key":"1067_CR36","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nature11378","volume":"490","author":"R Schmitz","year":"2012","unstructured":"Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature. 2012;490(7418):116\u201320.","journal-title":"Nature"},{"issue":"12","key":"1067_CR37","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/ng.2468","volume":"44","author":"C Love","year":"2012","unstructured":"Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, et al. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet. 2012;44(12):1321\u20135.","journal-title":"Nat Genet"},{"issue":"8","key":"1067_CR38","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrc2664","volume":"9","author":"JA Engelman","year":"2009","unstructured":"Engelman JA. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer. 2009;9(8):550\u201362.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"1067_CR39","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","volume":"24","author":"B Chapuy","year":"2018","unstructured":"Chapuy B, Stewart C, Dunford AJ, Kim J, Kamburov A, Redd RA, et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med. 2018;24(5):679\u201390.","journal-title":"Nat Med"},{"issue":"4","key":"1067_CR40","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1158\/2326-6066.CIR-17-0218","volume":"6","author":"MF Eissmann","year":"2018","unstructured":"Eissmann MF, Dijkstra C, Wouters MA, Baloyan D, Mouradov D, Nguyen PM, et al. Interleukin 33 signaling restrains sporadic colon cancer in an interferon-\u03b3-dependent manner. Cancer Immunol Res. 2018;6(4):409\u201321.","journal-title":"Cancer Immunol Res"},{"issue":"2","key":"1067_CR41","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1182\/blood-2014-12-575688","volume":"126","author":"R Somasundaram","year":"2015","unstructured":"Somasundaram R, Prasad MA, Ungerb\u00e4ck J, Sigvardsson M. Transcription factor networks in B-cell differentiation link development to acute lymphoid leukemia. Blood. 2015;126(2):144\u201352.","journal-title":"Blood"},{"issue":"15","key":"1067_CR42","doi-asserted-by":"publisher","first-page":"4936","DOI":"10.1158\/1078-0432.CCR-10-1499","volume":"17","author":"L Li","year":"2011","unstructured":"Li L, Bhatia R. Stem cell quiescence. Clin Cancer Res. 2011;17(15):4936\u201341.","journal-title":"Clin Cancer Res"},{"key":"1067_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.216022","volume":"554","author":"Y Tian","year":"2023","unstructured":"Tian Y, Xu L, Li X, Li H, Zhao M. SMARCA4: current status and future perspectives in non-small-cell lung cancer. Cancer Lett. 2023;554: 216022.","journal-title":"Cancer Lett"},{"issue":"1","key":"1067_CR44","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1172\/JCI69738","volume":"124","author":"AC West","year":"2014","unstructured":"West AC, Johnstone RW. New and emerging HDAC inhibitors for cancer treatment. J Clin Invest. 2014;124(1):30\u20139.","journal-title":"J Clin Invest"},{"issue":"20","key":"1067_CR45","doi-asserted-by":"publisher","first-page":"4831","DOI":"10.1002\/j.1460-2075.1994.tb06809.x","volume":"13","author":"I Wadman","year":"1994","unstructured":"Wadman I, Li J, Bash RO, Forster A, Osada H, Rabbitts TH, et al. Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia. Embo j. 1994;13(20):4831\u20139.","journal-title":"Embo j"},{"issue":"6673","key":"1067_CR46","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/32588","volume":"392","author":"J Banchereau","year":"1998","unstructured":"Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392(6673):245\u201352.","journal-title":"Nature"},{"key":"1067_CR47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.smim.2017.12.002","volume":"35","author":"C Qian","year":"2018","unstructured":"Qian C, Cao X. Dendritic cells in the regulation of immunity and inflammation. Semin Immunol. 2018;35:3\u201311.","journal-title":"Semin Immunol"},{"issue":"1","key":"1067_CR48","doi-asserted-by":"publisher","first-page":"5184","DOI":"10.1038\/s41467-022-32849-1","volume":"13","author":"J Adamik","year":"2022","unstructured":"Adamik J, Munson PV, Hartmann FJ, Combes AJ, Pierre P, Krummel MF, et al. Distinct metabolic states guide maturation of inflammatory and tolerogenic dendritic cells. Nat Commun. 2022;13(1):5184.","journal-title":"Nat Commun"},{"issue":"1","key":"1067_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110609","volume":"39","author":"S Li","year":"2022","unstructured":"Li S, Yu J, Huber A, Kryczek I, Wang Z, Jiang L, et al. Metabolism drives macrophage heterogeneity in the tumor microenvironment. Cell Rep. 2022;39(1): 110609.","journal-title":"Cell Rep"},{"issue":"3","key":"1067_CR50","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.immuni.2023.01.011","volume":"56","author":"SK Wculek","year":"2023","unstructured":"Wculek SK, Heras-Murillo I, Mastrangelo A, Ma\u00f1anes D, Gal\u00e1n M, Miguel V, et al. Oxidative phosphorylation selectively orchestrates tissue macrophage homeostasis. Immunity. 2023;56(3):516-30.e9.","journal-title":"Immunity"},{"issue":"23","key":"1067_CR51","doi-asserted-by":"publisher","first-page":"5770","DOI":"10.1158\/1078-0432.CCR-10-1025","volume":"16","author":"YC Pan","year":"2010","unstructured":"Pan YC, Li CF, Ko CY, Pan MH, Chen PJ, Tseng JT, et al. CEBPD reverses RB\/E2F1-mediated gene repression and participates in HMDB-induced apoptosis of cancer cells. Clin Cancer Res. 2010;16(23):5770\u201380.","journal-title":"Clin Cancer Res"},{"key":"1067_CR52","doi-asserted-by":"crossref","unstructured":"Kayagaki N, Lee BL, Stowe IB, Kornfeld OS, O\u2019Rourke K, Mirrashidi KM, et al. IRF2 transcriptionally induces GSDMD expression for pyroptosis. Sci Signal. 2019;12(582).","DOI":"10.1126\/scisignal.aax4917"},{"issue":"4","key":"1067_CR53","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.immuni.2021.03.007","volume":"54","author":"M Delacher","year":"2021","unstructured":"Delacher M, Simon M, Sanderink L, Hotz-Wagenblatt A, Wuttke M, Schambeck K, et al. Single-cell chromatin accessibility landscape identifies tissue repair program in human regulatory T cells. Immunity. 2021;54(4):702-20.e17.","journal-title":"Immunity"},{"issue":"14","key":"1067_CR54","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1158\/1078-0432.CCR-19-4044","volume":"26","author":"R Kandimalla","year":"2020","unstructured":"Kandimalla R, Tomihara H, Banwait JK, Yamamura K, Singh G, Baba H, et al. A 15-gene immune, stromal, and proliferation gene signature that significantly associates with poor survival in patients with pancreatic ductal adenocarcinoma. Clin Cancer Res. 2020;26(14):3641\u20138.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1067_CR55","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103(1):275\u201382.","journal-title":"Blood"},{"issue":"9","key":"1067_CR56","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1101\/gad.1067003","volume":"17","author":"PC Fernandez","year":"2003","unstructured":"Fernandez PC, Frank SR, Wang L, Schroeder M, Liu S, Greene J, et al. Genomic targets of the human c-Myc protein. Genes Dev. 2003;17(9):1115\u201329.","journal-title":"Genes Dev"},{"issue":"2","key":"1067_CR57","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1158\/1940-6207.CAPR-09-0166","volume":"3","author":"TP Forshell","year":"2010","unstructured":"Forshell TP, Rimpi S, Nilsson JA. Chemoprevention of B-cell lymphomas by inhibition of the myc target spermidine synthase. Cancer Prev Res. 2010;3(2):140\u20137.","journal-title":"Cancer Prev Res"},{"issue":"7","key":"1067_CR58","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1182\/bloodadvances.2021004618","volume":"6","author":"K Miyawaki","year":"2022","unstructured":"Miyawaki K, Kato K, Sugio T, Sasaki K, Miyoshi H, Semba Y, et al. A germinal center-associated microenvironmental signature reflects malignant phenotype and outcome of DLBCL. Blood Adv. 2022;6(7):2388\u2013402.","journal-title":"Blood Adv"}],"container-title":["Journal of Big Data"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40537-025-01067-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40537-025-01067-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40537-025-01067-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T16:57:07Z","timestamp":1737651427000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalofbigdata.springeropen.com\/articles\/10.1186\/s40537-025-01067-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1067"],"URL":"https:\/\/doi.org\/10.1186\/s40537-025-01067-z","relation":{},"ISSN":["2196-1115"],"issn-type":[{"value":"2196-1115","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,23]]},"assertion":[{"value":"5 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}